Activity of Eugenia jambolana, an ethnomedical plant, against drug-resistant bacteria

被引:2
|
作者
Jasmine, R. [3 ]
Selvakumar, B. N. [2 ]
Daisy, P. [3 ]
Ignacimuthu, S. [1 ]
机构
[1] Loyola Coll, Entomol Res Inst, Madras 600034, Tamil Nadu, India
[2] CSI Mission Gen Hosp, Dept Microbiol, Tiruchirappalli, Tamil Nadu, India
[3] Coll Holy Cross, Dept Biotechnol, Tiruchirappalli, Tamil Nadu, India
关键词
Eugenia jambolana; antibacterial activity; extended spectrum beta-lactamase; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIBACTERIAL; EXTRACTS;
D O I
10.3109/13880200903150401
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Seeds of Eugenia jambolana Lam. (Myrtaceae) are used by many tribes in India to treat diarrhea and dysentery. The crude extracts of seeds of this plant demonstrated zones of inhibition in the range of 14- 21 mm against the isolated beta-lactamase-producing drug-resistant bacteria. The methanol extract showed promising antibacterial activity which was subjected to fractionation. The effective fraction (F2) showed a minimum inhibitory concentration (MIC) ranging from 31.75 to 62.5 mu g/mL. Phytochemical analysis and thin layer chromatography of the most promising fraction showed the presence of saponin as the active phytoconstituent. The active fraction was further tested for its in vitro hemolytic activity in sheep and human erythrocytes and no hemolysis was seen. Thus, the use of this plant by tribals to treat bacterial infections has some scientific basis.</.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 50 条
  • [41] The deadly burden of drug-resistant bacteria
    Asher Mullard
    Nature Reviews Drug Discovery, 2022, 21 : 170 - 170
  • [42] Restoring sensitivity to drug-resistant bacteria
    Lund, AE
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1997, 128 (10): : 1362 - 1362
  • [43] Science - Drug-resistant bacteria tamed
    Stinson, S
    CHEMICAL & ENGINEERING NEWS, 2001, 79 (35) : 16 - 16
  • [44] Travel and the Spread of Drug-Resistant Bacteria
    Kevin L. Schwartz
    Shaun K. Morris
    Current Infectious Disease Reports, 2018, 20
  • [45] Drug-resistant bacteria in hospitalized patients
    不详
    AMERICAN JOURNAL OF NURSING, 2006, 106 (09) : 72L - 72L
  • [46] The deadly burden of drug-resistant bacteria
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (03) : 170 - 170
  • [47] Mutasynthesis of Lincomycin Derivatives with Activity against Drug-Resistant Staphylococci
    Ulanova, Dana
    Novotna, Jitka
    Smutna, Yvona
    Kamenik, Zdenek
    Gazak, Radek
    Sulc, Miroslav
    Sedmera, Petr
    Kadlcik, Stanislav
    Plhackova, Kamila
    Janata, Jiri
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (02) : 927 - 930
  • [48] Synthesis and structure-activity-relationships of fluoroquinolone dimers possessing antibacterial activity against drug-resistant bacteria.
    Kerns, RJ
    Vaka, F
    Cha, R
    Rybak, MJ
    Kaatz, GW
    Diwadkar, V
    Grucz, RG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U15 - U15
  • [49] Anti-CRISPR proteins as a therapeutic agent against drug-resistant bacteria
    Vyas, Pallavi
    Harish
    MICROBIOLOGICAL RESEARCH, 2022, 257
  • [50] INFECTION - PROSPECTS FOR TREATMENT AND PREVENTION - DRUGS FOR USE AGAINST DRUG-RESISTANT BACTERIA
    YOKOTA, T
    JAPANESE JOURNAL OF CLINICAL MEDICINE, 1981, 39 (06): : 132 - 137